Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)

NCT04573881 is registered in ClinicalTrials.gov with HistoSonics, Inc. as lead sponsor.

NCT NCT04573881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04573881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)
Lead sponsor
HistoSonics, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 4, 2021
Completion date
August 31, 2027
Enrollment
24 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver metastases, liver neoplasms